Treatment of moderate-to-severe atopic dermatitis with baricitinib: Results from an interim analysis of the TREATgermany registry

Traidl S, Heinrich L, Siegels D, Heratizadeh A, Kind B, Haufe E, Abraham S, Schäfer T, Augustin M, Harder I, Pinter A, Schäkel K, Wollenberg A, Ertner K, Ramaker-Brunke J, Bong A, Quist S, Gorriahn-Maiterth H, Schenck F, Sticherling M, Effendy I, Schwarz B, Handrick C, Asmussen A, Weidinger S, Schmitt J, Werfel T (2024)

Publication Type: Journal article

Publication year: 2024

Journal

Journal of the European Academy of Dermatology and Venereology Wiley-Blackwell

DOI: 10.1111/jdv.19979

Authors with CRIS profile

Michael Sticherling Professur für Dermatologie

Additional Organisation(s)

FAU Profilzentrum Licht.Materie.Quantentechnologien (FAU LMQ)

Involved external institutions

Medizinische Hochschule Hannover (MHH) / Hannover Medical School

Germany (DE) Universitätsklinikum Carl Gustav Carus Dresden

Germany (DE) Universitätsklinikum Hamburg-Eppendorf (UKE)

Germany (DE) Universitätsklinikum Schleswig-Holstein (UKSH)

Germany (DE) Universitätsklinikum Frankfurt am Main (KGU)

Germany (DE) Ruprecht-Karls-Universität Heidelberg

Germany (DE) Ludwig-Maximilians-Universität (LMU)

Germany (DE) Helix Mainz GmbH & Co. KG

Germany (DE) Universität Bielefeld

Germany (DE)

How to cite

APA:

Traidl, S., Heinrich, L., Siegels, D., Heratizadeh, A., Kind, B., Haufe, E.,... Werfel, T. (2024). Treatment of moderate-to-severe atopic dermatitis with baricitinib: Results from an interim analysis of the TREATgermany registry. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.19979

MLA:

Traidl, Stephan, et al. "Treatment of moderate-to-severe atopic dermatitis with baricitinib: Results from an interim analysis of the TREATgermany registry." Journal of the European Academy of Dermatology and Venereology (2024).

BibTeX: Download